Figure 3

ROC curve analysis for different clinicopathological parameters and CHD1L protein expression was performed to evaluate the survival status. FIGO stage (area under the curve [AUC] =0.755, P<0.001), CHD1L protein expression ([AUC] =0.622, P<0.05), Residual tumor ([AUC] =0.737, P<0.001), Pathological grade ([AUC] =0.681, P<0.001) implied significant statistical associations with the survival.